Abstract
Carcinoma of the uterine cervix is a common malignancy among women that has been found to show loss of heterozygosity in the chromosome 11p. Recent studies have localized the TSG101 gene in this region, and also demonstrated a high frequency of abnormalities of this gene in human breast cancer. To determine the role of the TSG101 gene in the carcinogenesis of cervical and uterine carcinoma, 19 cases of cervical carcinoma and five cases of endometrial carcinoma, as well as nearby non-cancerous tissue from the same patients, and 16 blood samples from healthy persons as normal control were analysed by Southern blot analysis of genomic DNA, reverse transcription of the TSG101 mRNA followed by PCR amplification and sequencing of the products. We found that abnormal transcripts of the TSG101 gene were common both in cancerous or non-cancerous tissues of the uterus and cervix and in normal peripheral mononuclear cells. There was no genomic deletion or rearrangement in spite of the presence of abnormal transcripts, and no definite relationship between the abnormal transcripts and HPV infection was found. Although the frequency of abnormal transcripts was higher in cancerous than in non-cancerous tissue, normal peripheral mononuclear cells also had abnormal transcripts. Given these findings, the role of the TSG101 gene as a tumour-suppressor gene should be re-evaluated. Because some aberrant transcripts could be found at the first PCR reaction, we suggest that the aberrant transcripts might be the result of imperfect minor splicesome products. © 1999 Cancer Research Campaign
Keywords: TSG101 gene, transcripts, cervical cancer, endometrial cancer, tumour-suppressor gene
Full Text
The Full Text of this article is available as a PDF (325.5 KB).
Footnotes
This study had been presented as a poster at the 47th Annual Meeting of the American Society of Human Genetics. Drs JG Chang and TH Su have made equal contributions to this study.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chen Y. J., Chang J. G., Shih L. S., Chen P. H., Endo M., Whang-Peng J., Chen Y. M. Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. Int J Cancer. 1997 May 2;71(3):350–354. doi: 10.1002/(sici)1097-0215(19970502)71:3<350::aid-ijc7>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
- Fujinaga Y., Shimada M., Okazawa K., Fukushima M., Kato I., Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol. 1991 May;72(Pt 5):1039–1044. doi: 10.1099/0022-1317-72-5-1039. [DOI] [PubMed] [Google Scholar]
- Lee M. P., Feinberg A. P. Aberrant splicing but not mutations of TSG101 in human breast cancer. Cancer Res. 1997 Aug 1;57(15):3131–3134. [PubMed] [Google Scholar]
- Li L., Cohen S. N. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell. 1996 May 3;85(3):319–329. doi: 10.1016/s0092-8674(00)81111-3. [DOI] [PubMed] [Google Scholar]
- Li L., Li X., Francke U., Cohen S. N. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell. 1997 Jan 10;88(1):143–154. doi: 10.1016/s0092-8674(00)81866-8. [DOI] [PubMed] [Google Scholar]
- Lin S. Y., Chen P. H., Wang C. K., Liu J. D., Siauw C. P., Chen Y. J., Yang M. J., Liu M. H., Chen T. C., Chang J. G. Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method. Am J Clin Pathol. 1993 Dec;100(6):686–689. doi: 10.1093/ajcp/100.6.686. [DOI] [PubMed] [Google Scholar]
- Marshall C. J. Tumor suppressor genes. Cell. 1991 Jan 25;64(2):313–326. doi: 10.1016/0092-8674(91)90641-b. [DOI] [PubMed] [Google Scholar]
- Murthy N. S., Sehgal A., Satyanarayana L., Das D. K., Singh V., Das B. C., Gupta M. M., Mitra A. B., Luthra U. K. Risk factors related to biological behaviour of precancerous lesions of the uterine cervix. Br J Cancer. 1990 May;61(5):732–736. doi: 10.1038/bjc.1990.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shridhar R., Shridhar V., Wang X., Paradee W., Dugan M., Sarkar F., Wilke C., Glover T. W., Vaitkevicius V. K., Smith D. I. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res. 1996 Oct 1;56(19):4347–4350. [PubMed] [Google Scholar]
- Steiner P., Barnes D. M., Harris W. H., Weinberg R. A. Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer. Nat Genet. 1997 Aug;16(4):332–333. doi: 10.1038/ng0897-332. [DOI] [PubMed] [Google Scholar]
- Wahi P. N., Mali S., Luthra U. K. Factors influencing cancer of the uterine cervix in North India. Cancer. 1969 May;23(5):1221–1226. doi: 10.1002/1097-0142(196905)23:5<1221::aid-cncr2820230532>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]